Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2012

01.05.2012 | Epidemiology

Structural/organizational characteristics of health services partly explain racial variation in timeliness of radiation therapy among elderly breast cancer patients

verfasst von: Stephanie B. Wheeler, William R. Carpenter, Jeffrey Peppercorn, Anna P. Schenck, Morris Weinberger, Andrea K. Biddle

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Observed racial/ethnic disparities in the process and outcomes of breast cancer care may be explained, in part, by structural/organizational characteristics of health care systems. We examined the role of surgical facility characteristics and distance to care in explaining racial/ethnic variation in timing of initiation of guideline-recommended radiation therapy (RT) after breast conserving surgery (BCS). We used Surveillance Epidemiology and End Results-Medicare data to identify women ages 65 and older diagnosed with stages I–III breast cancer and treated with BCS in 1994–2002. We used stepwise multivariate logistic regression to examine the interactive effects of race/ethnicity and facility profit status, teaching status, size, and institutional affiliations, and distance to nearest RT on timing of RT initiation, controlling for known covariates. Among 38,574 eligible women who received BCS, 39% received RT within 2 months, 52% received RT within 6 months, and 57% received RT within 12 months post-diagnosis, with significant variation by race/ethnicity. In multivariate models, women attending smaller surgical facilities and those with on-site radiation had higher odds of RT at each time interval, and women attending governmental facilities had lower odds of RT at each time interval (P < 0.05). Increasing distance between patients’ residence and nearest RT provider was associated with lower overall odds of RT, particularly among Hispanic women (P < 0.05). In fully adjusted models including race-by-distance interaction terms, racial/ethnic disparities disappeared in RT initiation within 6 and 12 months. Racial/ethnic disparities in timing of RT for breast cancer can be partially explained by structural/organizational health system characteristics. Identifying modifiable system-level factors associated with quality cancer care may help us target policy interventions that can reduce disparities in outcomes.
Literatur
1.
Zurück zum Zitat Onega T, Duell EJ, Shi X, Demidenko E, Gottlieb D, Goodman DC (2009) Influence of NCI-cancer center attendance on mortality in lung, breast, colorectal, and prostate cancer patients. Med Care Res Rev 66:542–560PubMedCrossRef Onega T, Duell EJ, Shi X, Demidenko E, Gottlieb D, Goodman DC (2009) Influence of NCI-cancer center attendance on mortality in lung, breast, colorectal, and prostate cancer patients. Med Care Res Rev 66:542–560PubMedCrossRef
2.
Zurück zum Zitat Laliberte L, Fennell ML, Papandonatos G (2005) The relationship of membership in research networks to compliance with treatment guidelines for early-stage breast cancer. Med Care 43(5):471–479PubMedCrossRef Laliberte L, Fennell ML, Papandonatos G (2005) The relationship of membership in research networks to compliance with treatment guidelines for early-stage breast cancer. Med Care 43(5):471–479PubMedCrossRef
3.
Zurück zum Zitat Keating NL, Landrum MB, Ayanian JZ, Winer EP, Guadagnoli E (2003) Consultation with a medical oncologist before surgery and type of surgery among elderly women with early-stage breast cancer. J Clin Oncol 21(24):4532–4539PubMedCrossRef Keating NL, Landrum MB, Ayanian JZ, Winer EP, Guadagnoli E (2003) Consultation with a medical oncologist before surgery and type of surgery among elderly women with early-stage breast cancer. J Clin Oncol 21(24):4532–4539PubMedCrossRef
4.
Zurück zum Zitat Keating NL, Kouri E, He Y, Weeks JC, Winer EP (2009) Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery? Med Care 47(7):765–773PubMedCrossRef Keating NL, Kouri E, He Y, Weeks JC, Winer EP (2009) Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery? Med Care 47(7):765–773PubMedCrossRef
5.
Zurück zum Zitat Jerome-D’Emilia B, Begun JW (2005) Diffusion of breast conserving surgery in medical communities. Soc Sci Med 60(1):143–151PubMedCrossRef Jerome-D’Emilia B, Begun JW (2005) Diffusion of breast conserving surgery in medical communities. Soc Sci Med 60(1):143–151PubMedCrossRef
6.
Zurück zum Zitat Hebert-Croteau N, Brisson J, Lemaire J, Latreille J, Pineault R (2005) Investigating the correlation between hospital of primary treatment and the survival of women with breast cancer. Cancer 104(7):1343–1348PubMedCrossRef Hebert-Croteau N, Brisson J, Lemaire J, Latreille J, Pineault R (2005) Investigating the correlation between hospital of primary treatment and the survival of women with breast cancer. Cancer 104(7):1343–1348PubMedCrossRef
7.
Zurück zum Zitat Haggstrom DA, Quale C, Smith-Bindman R (2005) Differences in the quality of breast cancer care among vulnerable populations. Cancer 104(11):2347–2358PubMedCrossRef Haggstrom DA, Quale C, Smith-Bindman R (2005) Differences in the quality of breast cancer care among vulnerable populations. Cancer 104(11):2347–2358PubMedCrossRef
8.
Zurück zum Zitat Ballard-Barbash R, Potosky AL, Harlan LC, Nayfield SG, Kessler LG (1996) Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 88(11):716–726PubMedCrossRef Ballard-Barbash R, Potosky AL, Harlan LC, Nayfield SG, Kessler LG (1996) Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 88(11):716–726PubMedCrossRef
9.
Zurück zum Zitat Bickell NA (2002) Race, ethnicity, and disparities in breast cancer: victories and challenges. Womens Health Issues 12(5):238–251PubMedCrossRef Bickell NA (2002) Race, ethnicity, and disparities in breast cancer: victories and challenges. Womens Health Issues 12(5):238–251PubMedCrossRef
10.
Zurück zum Zitat Bickell NA, McEvoy MD (2003) Physicians’ reasons for failing to deliver effective breast cancer care: a framework for underuse. Med Care 41(3):442–446PubMed Bickell NA, McEvoy MD (2003) Physicians’ reasons for failing to deliver effective breast cancer care: a framework for underuse. Med Care 41(3):442–446PubMed
11.
12.
Zurück zum Zitat Chaudhry R, Goel V, Sawka C (2001) Breast cancer survival by teaching status of the initial treating hospital. CMAJ 164(2):183–188PubMed Chaudhry R, Goel V, Sawka C (2001) Breast cancer survival by teaching status of the initial treating hospital. CMAJ 164(2):183–188PubMed
13.
Zurück zum Zitat Gilligan MA, Neuner J, Sparapani R, Laud PW, Nattinger AB (2007) Surgeon characteristics and variations in treatment for early-stage breast cancer. Arch Surg 142(1):17–22PubMedCrossRef Gilligan MA, Neuner J, Sparapani R, Laud PW, Nattinger AB (2007) Surgeon characteristics and variations in treatment for early-stage breast cancer. Arch Surg 142(1):17–22PubMedCrossRef
14.
Zurück zum Zitat Gilligan MA, Neuner J, Zhang X, Sparapani R, Laud PW, Nattinger AB (2007) Relationship between number of breast cancer operations performed and 5-year survival after treatment for early-stage breast cancer. Am J Public Health 97(3):539–544PubMedCrossRef Gilligan MA, Neuner J, Zhang X, Sparapani R, Laud PW, Nattinger AB (2007) Relationship between number of breast cancer operations performed and 5-year survival after treatment for early-stage breast cancer. Am J Public Health 97(3):539–544PubMedCrossRef
15.
Zurück zum Zitat Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC, Friedman C, Harlan L, Warren J, Anderson RN, Pickle LW (2005) Annual report to the nation on the status of cancer, 1975–2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97(19):1407–1427PubMedCrossRef Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC, Friedman C, Harlan L, Warren J, Anderson RN, Pickle LW (2005) Annual report to the nation on the status of cancer, 1975–2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97(19):1407–1427PubMedCrossRef
16.
Zurück zum Zitat Freedman RA, He Y, Winer EP, Keating NL (2009) Trends in racial and age disparities in definitive local therapy of early-stage breast cancer. J Clin Oncol 27(5):713–719PubMedCrossRef Freedman RA, He Y, Winer EP, Keating NL (2009) Trends in racial and age disparities in definitive local therapy of early-stage breast cancer. J Clin Oncol 27(5):713–719PubMedCrossRef
17.
Zurück zum Zitat Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295(21):2492–2502PubMedCrossRef Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295(21):2492–2502PubMedCrossRef
18.
Zurück zum Zitat Du XL, Fang S, Meyer TE (2008) Impact of treatment and socioeconomic status on racial disparities in survival among older women with breast cancer. Am J Clin Oncol 31(2):125–132PubMedCrossRef Du XL, Fang S, Meyer TE (2008) Impact of treatment and socioeconomic status on racial disparities in survival among older women with breast cancer. Am J Clin Oncol 31(2):125–132PubMedCrossRef
19.
Zurück zum Zitat Gross CP, Smith BD, Wolf E, Andersen M (2008) Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002? Cancer 112(4):900–908PubMedCrossRef Gross CP, Smith BD, Wolf E, Andersen M (2008) Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002? Cancer 112(4):900–908PubMedCrossRef
20.
Zurück zum Zitat Lund MJ, Trivers KF, Porter PL, Coates RJ, Leyland-Jones B, Brawley OW, Flagg EW, O’Regan RM, Gabram SG, Eley JW (2009) Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat 113(2):357–370PubMedCrossRef Lund MJ, Trivers KF, Porter PL, Coates RJ, Leyland-Jones B, Brawley OW, Flagg EW, O’Regan RM, Gabram SG, Eley JW (2009) Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat 113(2):357–370PubMedCrossRef
21.
Zurück zum Zitat Schootman M, Jeffe DB, Gillanders WE, Aft R (2009) Racial disparities in the development of breast cancer metastases among older women: a multilevel study. Cancer 115(4):731–740PubMedCrossRef Schootman M, Jeffe DB, Gillanders WE, Aft R (2009) Racial disparities in the development of breast cancer metastases among older women: a multilevel study. Cancer 115(4):731–740PubMedCrossRef
22.
Zurück zum Zitat Punglia RS, Weeks JC, Neville BA, Earle CC (2006) Effect of distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly women. Int J Radiat Oncol Biol Phys 66(1):56–63PubMedCrossRef Punglia RS, Weeks JC, Neville BA, Earle CC (2006) Effect of distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly women. Int J Radiat Oncol Biol Phys 66(1):56–63PubMedCrossRef
23.
Zurück zum Zitat Birkmeyer NJ, Goodney PP, Stukel TA, Hillner BE, Birkmeyer JD (2005) Do cancer centers designated by the National Cancer Institute have better surgical outcomes? Cancer 103(3):435–441PubMedCrossRef Birkmeyer NJ, Goodney PP, Stukel TA, Hillner BE, Birkmeyer JD (2005) Do cancer centers designated by the National Cancer Institute have better surgical outcomes? Cancer 103(3):435–441PubMedCrossRef
25.
Zurück zum Zitat Harris SR, Olivotto IA, Levine M (1991) NIH consensus conference. Treatment of early-stage breast cancer. JAMA 265(3):391–395CrossRef Harris SR, Olivotto IA, Levine M (1991) NIH consensus conference. Treatment of early-stage breast cancer. JAMA 265(3):391–395CrossRef
26.
Zurück zum Zitat Greenhalgh T, Robert G, Macfarlane F, Bate P, Kyriakidou O (2004) Diffusion of innovations in service organizations: systematic review and recommendations. Milbank Q 82(4):581–629PubMedCrossRef Greenhalgh T, Robert G, Macfarlane F, Bate P, Kyriakidou O (2004) Diffusion of innovations in service organizations: systematic review and recommendations. Milbank Q 82(4):581–629PubMedCrossRef
27.
Zurück zum Zitat Rogers EM (1995) Lessons for guidelines from the diffusion of innovations. Jt Comm J Qual Improv 21(7):324–328PubMed Rogers EM (1995) Lessons for guidelines from the diffusion of innovations. Jt Comm J Qual Improv 21(7):324–328PubMed
28.
Zurück zum Zitat Bowen S, Zwi AB (2005) Pathways to “evidence-informed” policy and practice: a framework for action. PLoS Med 2(7):e166PubMedCrossRef Bowen S, Zwi AB (2005) Pathways to “evidence-informed” policy and practice: a framework for action. PLoS Med 2(7):e166PubMedCrossRef
29.
Zurück zum Zitat Birkmeyer JD, Siewers AE, Marth NJ, Goodman DC (2003) Regionalization of high-risk surgery and implications for patient travel times. JAMA 290(20):2703–2708PubMedCrossRef Birkmeyer JD, Siewers AE, Marth NJ, Goodman DC (2003) Regionalization of high-risk surgery and implications for patient travel times. JAMA 290(20):2703–2708PubMedCrossRef
30.
Zurück zum Zitat Coughlin SS, Sabatino SA, Shaw KM (2008) What factors are associated with where women undergo clinical breast examination? Results from the 2005 national health interview survey. Open Clin Cancer J 2:32–43PubMedCrossRef Coughlin SS, Sabatino SA, Shaw KM (2008) What factors are associated with where women undergo clinical breast examination? Results from the 2005 national health interview survey. Open Clin Cancer J 2:32–43PubMedCrossRef
31.
Zurück zum Zitat Bickell N, Mendez J, Guth A (2005) The quality of early-stage breast cancer treatment: what can we do to improve? Surg Oncol Clin N Am 14(1):103PubMedCrossRef Bickell N, Mendez J, Guth A (2005) The quality of early-stage breast cancer treatment: what can we do to improve? Surg Oncol Clin N Am 14(1):103PubMedCrossRef
32.
Zurück zum Zitat Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF (2002) Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40(8 Suppl):IV-3–18 Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF (2002) Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40(8 Suppl):IV-3–18
33.
Zurück zum Zitat Schrag D, Bach PB, Dahlman C, Warren JL (2002) Identifying and measuring hospital characteristics using the SEER-Medicare data and other claims-based sources. Med Care 40(8 Suppl):IV-96–103 Schrag D, Bach PB, Dahlman C, Warren JL (2002) Identifying and measuring hospital characteristics using the SEER-Medicare data and other claims-based sources. Med Care 40(8 Suppl):IV-96–103
34.
Zurück zum Zitat Bach PB, Guadagnoli E, Schrag D, Schussler N, Warren JL (2002) Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care 40(8 Suppl):IV-19–25 Bach PB, Guadagnoli E, Schrag D, Schussler N, Warren JL (2002) Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care 40(8 Suppl):IV-19–25
35.
Zurück zum Zitat Hickey BE, Francis D, Lehman MH (2006) Sequencing of chemotherapy and radiation therapy for early breast cancer. Cochrane Database Syst Rev 18(4):CD005212 Hickey BE, Francis D, Lehman MH (2006) Sequencing of chemotherapy and radiation therapy for early breast cancer. Cochrane Database Syst Rev 18(4):CD005212
36.
Zurück zum Zitat Blum JL, Jones SE, Fay JW, Senzer N, Mennel RG (1997) Guidelines for systemic therapy of early stage breast cancer. Breast Cancer Res Treat 43(3):259–276PubMedCrossRef Blum JL, Jones SE, Fay JW, Senzer N, Mennel RG (1997) Guidelines for systemic therapy of early stage breast cancer. Breast Cancer Res Treat 43(3):259–276PubMedCrossRef
37.
Zurück zum Zitat Desch CE, McNiff KK, Schneider EC, Schrag D, McClure J, Lepisto E, Donaldson MS, Kahn KL, Weeks JC, Ko CY, Stewart AK, Edge SB (2008) American society of clinical oncology/national comprehensive cancer network quality measures. J Clin Oncol 26(21):3631–3637PubMedCrossRef Desch CE, McNiff KK, Schneider EC, Schrag D, McClure J, Lepisto E, Donaldson MS, Kahn KL, Weeks JC, Ko CY, Stewart AK, Edge SB (2008) American society of clinical oncology/national comprehensive cancer network quality measures. J Clin Oncol 26(21):3631–3637PubMedCrossRef
38.
Zurück zum Zitat Balduzzi A, Leonardi MC, Cardillo A, Orecchia R, Dellapasqua S, Iorfida M, Goldhirsch A, Colleoni M (2010) Timing of adjuvant systemic therapy and radiotherapy after breast-conserving surgery and mastectomy. Cancer Treat Rev 36(6):443–450. doi:10.1016/j.ctrv.2010.02.019 PubMedCrossRef Balduzzi A, Leonardi MC, Cardillo A, Orecchia R, Dellapasqua S, Iorfida M, Goldhirsch A, Colleoni M (2010) Timing of adjuvant systemic therapy and radiotherapy after breast-conserving surgery and mastectomy. Cancer Treat Rev 36(6):443–450. doi:10.​1016/​j.​ctrv.​2010.​02.​019 PubMedCrossRef
39.
Zurück zum Zitat Stitzenberg KB, Thomas NE, Ollila DW (2007) Influence of provider and practice characteristics on melanoma care. Am J Surg 193(2):206–212PubMedCrossRef Stitzenberg KB, Thomas NE, Ollila DW (2007) Influence of provider and practice characteristics on melanoma care. Am J Surg 193(2):206–212PubMedCrossRef
40.
Zurück zum Zitat Gort M, Broekhuis M, Otter R, Klazinga NS (2007) Improvement of best practice in early breast cancer: actionable surgeon and hospital factors. Breast Cancer Res Treat 102(2):219–226PubMedCrossRef Gort M, Broekhuis M, Otter R, Klazinga NS (2007) Improvement of best practice in early breast cancer: actionable surgeon and hospital factors. Breast Cancer Res Treat 102(2):219–226PubMedCrossRef
41.
Zurück zum Zitat Lee-Feldstein A, Anton-Culver H, Feldstein PJ (1994) Treatment differences and other prognostic factors related to breast cancer survival. Delivery systems and medical outcomes. JAMA 271(15):1163–1168PubMedCrossRef Lee-Feldstein A, Anton-Culver H, Feldstein PJ (1994) Treatment differences and other prognostic factors related to breast cancer survival. Delivery systems and medical outcomes. JAMA 271(15):1163–1168PubMedCrossRef
42.
Zurück zum Zitat Shea AM, Curtis LH, Hammill BG, DiMartino LD, Abernethy AP, Schulman KA (2008) Association between the Medicare Modernization Act of 2003 and patient wait times and travel distance for chemotherapy. JAMA 300(2):189–196PubMedCrossRef Shea AM, Curtis LH, Hammill BG, DiMartino LD, Abernethy AP, Schulman KA (2008) Association between the Medicare Modernization Act of 2003 and patient wait times and travel distance for chemotherapy. JAMA 300(2):189–196PubMedCrossRef
43.
Zurück zum Zitat Voti L, Richardson LC, Reis IM, Fleming LE, Mackinnon J, Coebergh JW (2006) Treatment of local breast carcinoma in Florida: the role of the distance to radiation therapy facilities. Cancer 106(1):201–207PubMedCrossRef Voti L, Richardson LC, Reis IM, Fleming LE, Mackinnon J, Coebergh JW (2006) Treatment of local breast carcinoma in Florida: the role of the distance to radiation therapy facilities. Cancer 106(1):201–207PubMedCrossRef
44.
Zurück zum Zitat Talcott JA, Spain P, Clark JA, Carpenter WR, Do YK, Hamilton RJ, Galanko JA, Jackman A, Godley PA (2007) Hidden barriers between knowledge and behavior: the North Carolina prostate cancer screening and treatment experience. Cancer 109(8):1599–1606. doi:10.1002/cncr.22583 PubMedCrossRef Talcott JA, Spain P, Clark JA, Carpenter WR, Do YK, Hamilton RJ, Galanko JA, Jackman A, Godley PA (2007) Hidden barriers between knowledge and behavior: the North Carolina prostate cancer screening and treatment experience. Cancer 109(8):1599–1606. doi:10.​1002/​cncr.​22583 PubMedCrossRef
45.
Zurück zum Zitat Phibbs CS, Luft HS (1995) Correlation of travel time on roads versus straight line distance. Med Care Res Rev 52(4):532–542PubMedCrossRef Phibbs CS, Luft HS (1995) Correlation of travel time on roads versus straight line distance. Med Care Res Rev 52(4):532–542PubMedCrossRef
46.
Zurück zum Zitat Gerend MA, Pai M (2008) Social determinants of Black-White disparities in breast cancer mortality: a review. Cancer Epidemiol Biomark Prev 17(11):2913–2923CrossRef Gerend MA, Pai M (2008) Social determinants of Black-White disparities in breast cancer mortality: a review. Cancer Epidemiol Biomark Prev 17(11):2913–2923CrossRef
47.
Zurück zum Zitat Schueler KM, Chu PW, Smith-Bindman R (2008) Factors associated with mammography utilization: a systematic quantitative review of the literature. J Womens Health (Larchmt) 17(9):1477–1498CrossRef Schueler KM, Chu PW, Smith-Bindman R (2008) Factors associated with mammography utilization: a systematic quantitative review of the literature. J Womens Health (Larchmt) 17(9):1477–1498CrossRef
48.
Zurück zum Zitat Banerjee M, George J, Yee C, Hryniuk W, Schwartz K (2007) Disentangling the effects of race on breast cancer treatment. Cancer 110(10):2169–2177PubMedCrossRef Banerjee M, George J, Yee C, Hryniuk W, Schwartz K (2007) Disentangling the effects of race on breast cancer treatment. Cancer 110(10):2169–2177PubMedCrossRef
49.
Zurück zum Zitat Rothman KJ, Greenland S, Lash TL (2008) Modern Epidemiology, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, PA Rothman KJ, Greenland S, Lash TL (2008) Modern Epidemiology, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, PA
50.
Zurück zum Zitat Pagano M, Gauvreau K (2000) Principles of biostatistics, 2nd edn. Duxbury Press, Pacific Grove, CA Pagano M, Gauvreau K (2000) Principles of biostatistics, 2nd edn. Duxbury Press, Pacific Grove, CA
51.
Zurück zum Zitat Mickey RM, Greenland S (1989) The impact of confounder selection criteria on effect estimation. Am J Epidemiol 129(1):125–137PubMed Mickey RM, Greenland S (1989) The impact of confounder selection criteria on effect estimation. Am J Epidemiol 129(1):125–137PubMed
52.
Zurück zum Zitat Wooldridge JM (2006) Introductory econometrics—a modern approach. Thomson-Southwestern Publishing, Mason, OH Wooldridge JM (2006) Introductory econometrics—a modern approach. Thomson-Southwestern Publishing, Mason, OH
54.
Zurück zum Zitat Smith G, Shih Y, Xu Y, Giordano S, Smith B, Perkins G, Tereffe W, Woodward W, Buchholz T (2010) Racial disparities in the use of radiotherapy after breast conserving surgery: a national Medicare study. Cancer 116(3):734–741PubMedCrossRef Smith G, Shih Y, Xu Y, Giordano S, Smith B, Perkins G, Tereffe W, Woodward W, Buchholz T (2010) Racial disparities in the use of radiotherapy after breast conserving surgery: a national Medicare study. Cancer 116(3):734–741PubMedCrossRef
55.
Zurück zum Zitat Hershman DL, Buono D, McBride RB, Tsai WY, Joseph KA, Grann VR, Jacobson JS (2008) Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer. J Natl Cancer Inst 100(3):199–206PubMedCrossRef Hershman DL, Buono D, McBride RB, Tsai WY, Joseph KA, Grann VR, Jacobson JS (2008) Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer. J Natl Cancer Inst 100(3):199–206PubMedCrossRef
56.
Zurück zum Zitat Hughes KS, Schnaper LA, Berry D, Cirrincione C, McCormick B, Shank B, Wheeler J, Champion LA, Smith TJ, Smith BL, Shapiro C, Muss HB, Winer E, Hudis C, Wood W, Sugarbaker D, Henderson IC, Norton L (2004) Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351(10):971–977. doi:10.1056/NEJMoa040587 PubMedCrossRef Hughes KS, Schnaper LA, Berry D, Cirrincione C, McCormick B, Shank B, Wheeler J, Champion LA, Smith TJ, Smith BL, Shapiro C, Muss HB, Winer E, Hudis C, Wood W, Sugarbaker D, Henderson IC, Norton L (2004) Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351(10):971–977. doi:10.​1056/​NEJMoa040587 PubMedCrossRef
57.
Zurück zum Zitat Gold HT, Do HT, Dick AW (2008) Correlates and effect of suboptimal radiotherapy in women with ductal carcinoma in situ or early invasive breast cancer. Cancer 113(11):3108–3115PubMedCrossRef Gold HT, Do HT, Dick AW (2008) Correlates and effect of suboptimal radiotherapy in women with ductal carcinoma in situ or early invasive breast cancer. Cancer 113(11):3108–3115PubMedCrossRef
58.
Zurück zum Zitat Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI (2006) Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival. Int J Radiat Oncol Biol Phys 65(5):1353–1360PubMedCrossRef Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI (2006) Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival. Int J Radiat Oncol Biol Phys 65(5):1353–1360PubMedCrossRef
59.
Zurück zum Zitat Hebert-Croteau N, Freeman CR, Latreille J, Brisson J (2002) Delay in adjuvant radiation treatment and outcomes of breast cancer—a review. Breast Cancer Res Treat 74(1):77–94PubMedCrossRef Hebert-Croteau N, Freeman CR, Latreille J, Brisson J (2002) Delay in adjuvant radiation treatment and outcomes of breast cancer—a review. Breast Cancer Res Treat 74(1):77–94PubMedCrossRef
Metadaten
Titel
Structural/organizational characteristics of health services partly explain racial variation in timeliness of radiation therapy among elderly breast cancer patients
verfasst von
Stephanie B. Wheeler
William R. Carpenter
Jeffrey Peppercorn
Anna P. Schenck
Morris Weinberger
Andrea K. Biddle
Publikationsdatum
01.05.2012
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2012
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-012-1955-2

Weitere Artikel der Ausgabe 1/2012

Breast Cancer Research and Treatment 1/2012 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.